Cargando…
Letter: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21)
Autor principal: | Koo, Bo Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for the Study of Obesity
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017332/ https://www.ncbi.nlm.nih.gov/pubmed/33518535 http://dx.doi.org/10.7570/jomes20133 |
Ejemplares similares
-
Response: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21)
por: Hong, Ju-Young, et al.
Publicado: (2021) -
Letter: Factors Predicting Weight Loss after “Sleeve Gastrectomy with Loop Duodenojejunal Bypass” Surgery for Obesity (J Obes Metab Syndr 2020;29:208-14)
por: Park, Ji Yeon
Publicado: (2020) -
Response: In Situ Mobilization of Patients with Obesity as a Key Determinant of Weight Loss Interventions (J Obes Metab Syndr 2020;29:292-302)
por: Thivel, David, et al.
Publicado: (2022) -
Response: Factors Predicting Weight Loss after “Sleeve Gastrectomy with Loop Duodenojejunal Bypass” Surgery for Obesity (J Obes Metab Syndr 2020;29:208-14)
por: Vennapusa, Amar, et al.
Publicado: (2020) -
Addendum to: Three-Month Daily Consumption of Sugar-Sweetened Beverages Affects the Liver, Adipose Tissue, and Glucose Metabolism (J Obes Metab Syndr 2020;29:26-38)
por: Lee, Ghayoung, et al.
Publicado: (2022)